Expert opinion on investigational drugs

Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development. The Editors welcome: Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies Drug Evaluations reviewing the clinical and pharmacological data on a particular drug Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.

Expert Opinion on Investigational Drugs（ISSN 1354-3784 印刷版，ISSN 1744-7658 电子版）是一本国际性、同行评审的期刊，被MEDLINE索引收录。该期刊专注于发表关于临床前和早期临床开发阶段药物的评论文章和原创论文，旨在提供对未来药物开发方向的专家意见。此外，它还被多个摘要和索引服务所收录，包括Chemical Abstracts（CODEN: EOIDER）、Current Contents/Life Sciences、EMBASE/Excerpta Medica、Index Medicus/Medline、ISI Alerting Services以及Science Citations Index-Expanded。